Skip to content

Clinical trials

Terminated Lung Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Status: Terminated Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20033
20043
20052
20063
20073
20081
20093
20102
20114
20121
20131
20147
20151
20162
20176
20188
20195
20207
20213
20225
20233
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated84

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of New Mexico6
Aeris Therapeutics3
Blueprint Medicines Corporation3
InterMune3
AstraZeneca2
Complexa, Inc.2
Emory University2
Mallinckrodt2
University of Zurich2
Weill Medical College of Cornell University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases84
Respiratory Tract Diseases21
Lung Neoplasms15
Pulmonary Disease, Chronic Obstructive11
Thoracic Neoplasms10
Carcinoma, Non-Small-Cell Lung9
Neoplasms9
Neoplasms by Site8
Carcinoma, Bronchogenic7
Hypertension, Pulmonary7

Trials

Showing 51 to 75 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.